Literature DB >> 31311816

Daratumumab eradicates minimal residual disease in a preclinical model of pediatric T-cell acute lymphoblastic leukemia.

Fotini Vogiatzi1, Dorothee Winterberg1, Lennart Lenk1, Swantje Buchmann1, Gunnar Cario1, Martin Schrappe1, Matthias Peipp2, Paulina Richter-Pechanska3, Andreas E Kulozik3, Jana Lentes4, Anke K Bergmann4, Thomas Valerius2, Fabian-Simon Frielitz5, Christian Kellner6, Denis M Schewe1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31311816     DOI: 10.1182/blood.2019000904

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  12 in total

Review 1.  MRD-Based Therapeutic Decisions in Genetically Defined Subsets of Adolescents and Young Adult Philadelphia-Negative ALL.

Authors:  Manuela Tosi; Orietta Spinelli; Matteo Leoncin; Roberta Cavagna; Chiara Pavoni; Federico Lussana; Tamara Intermesoli; Luca Frison; Giulia Perali; Francesca Carobolante; Piera Viero; Cristina Skert; Alessandro Rambaldi; Renato Bassan
Journal:  Cancers (Basel)       Date:  2021-04-27       Impact factor: 6.639

Review 2.  Lymphoblastic Lymphoma: a Concise Review.

Authors:  Tamara Intermesoli; Alessandra Weber; Matteo Leoncin; Luca Frison; Cristina Skert; Renato Bassan
Journal:  Curr Oncol Rep       Date:  2022-01-20       Impact factor: 5.075

3.  Flow cytometric evaluation of CD38 expression levels in the newly diagnosed T-cell acute lymphoblastic leukemia and the effect of chemotherapy on its expression in measurable residual disease, refractory disease and relapsed disease: an implication for anti-CD38 immunotherapy.

Authors:  Prashant Ramesh Tembhare; Harshini Sriram; Twinkle Khanka; Gaurav Chatterjee; Devasis Panda; Sitaram Ghogale; Yajamanam Badrinath; Nilesh Deshpande; Nikhil V Patkar; Gaurav Narula; Bhausaheb Bagal; Hasmukh Jain; Manju Sengar; Navin Khattry; Shripad Banavali; Sumeet Gujral; Papagudi G Subramanian
Journal:  J Immunother Cancer       Date:  2020-05       Impact factor: 13.751

4.  CD79a promotes CNS-infiltration and leukemia engraftment in pediatric B-cell precursor acute lymphoblastic leukemia.

Authors:  Ameera Alsadeq; Denis M Schewe; Lennart Lenk; Michela Carlet; Fotini Vogiatzi; Lea Spory; Dorothee Winterberg; Antony Cousins; Michaela Vossen-Gajcy; Olta Ibruli; Christian Vokuhl; Gunnar Cario; Omar El Ayoubi; Lisa Kramer; Matthias Ritgen; Monika Brüggemann; Robert Häsler; Martin Schrappe; Stephan Fuhrmann; Christina Halsey; Irmela Jeremias; Elias Hobeika; Hassan Jumaa
Journal:  Commun Biol       Date:  2021-01-15

Review 5.  Natural killer cell therapy for hematologic malignancies: successes, challenges, and the future.

Authors:  Margaret G Lamb; Hemalatha G Rangarajan; Brian P Tullius; Dean A Lee
Journal:  Stem Cell Res Ther       Date:  2021-03-25       Impact factor: 6.832

Review 6.  Insights into Modern Therapeutic Approaches in Pediatric Acute Leukemias.

Authors:  Kinga Panuciak; Mikołaj Margas; Karolina Makowska; Monika Lejman
Journal:  Cells       Date:  2022-01-02       Impact factor: 6.600

7.  Daratumumab with or without chemotherapy in relapsed and refractory acute lymphoblastic leukemia. A retrospective observational Campus ALL study.

Authors:  Marco Cerrano; Massimiliano Bonifacio; Matteo Olivi; Antonio Curti; Michele Malagola; Michelina Dargenio; Anna Maria Scattolin; Cristina Papayannidis; Fabio Forghieri; Carmela Gurrieri; Ilaria Tanasi; Patrizia Zappasodi; Roberta La Starza; Nicola Stefano Fracchiolla; Patrizia Chiusolo; Luisa Giaccone; Maria Ilaria Del Principe; Fabio Giglio; Marzia Defina; Claudio Favre; Carmelo Rizzari; Barbara Castella; Giovanni Pizzolo; Felicetto Ferrara; Sabina Chiaretti; Robin Foà
Journal:  Haematologica       Date:  2022-04-01       Impact factor: 9.941

8.  Preclinical Evidence for the Efficacy of CD79b Immunotherapy in B-cell Precursor Acute Lymphoblastic Leukemia.

Authors:  Lennart Lenk; Dorothee Winterberg; Fotini Vogiatzi; Anna Laqua; Lea Spory; Ahmad Mayar; Anna Dietterle; Gina Münch; Christian Vokuhl; Julia Richter; Andrew G Polson; Thomas Schüler; Ulf D Kahlert; Matthias Peipp; Thomas Valerius; Martin Schrappe; Gunnar Cario; Hassan Jumaa; Elias Hobeika; Monika Brüggemann; Ameera Alsadeq; Denis M Schewe
Journal:  Hemasphere       Date:  2022-07-15

Review 9.  Facts and Challenges in Immunotherapy for T-Cell Acute Lymphoblastic Leukemia.

Authors:  Fátima Bayón-Calderón; María L Toribio; Sara González-García
Journal:  Int J Mol Sci       Date:  2020-10-16       Impact factor: 5.923

Review 10.  Invasive Fungal Diseases in Children with Hematological Malignancies Treated with Therapies That Target Cell Surface Antigens: Monoclonal Antibodies, Immune Checkpoint Inhibitors and CAR T-Cell Therapies.

Authors:  Ioannis Kyriakidis; Eleni Vasileiou; Claudia Rossig; Emmanuel Roilides; Andreas H Groll; Athanasios Tragiannidis
Journal:  J Fungi (Basel)       Date:  2021-03-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.